










Manoj Maniar | Onconova Therapeutics | Email, SVP Product Development, @onconova.com 











































LOGIN

7 DAY FREE TRIAL


























Manoj Maniar

 Onconova Therapeutics  SVP Product Development


Updated On : 
                    Apr 24, 2017                            

export

















375 Pheasant Run

Newtown, PA 18940


Email format for @onconova.com

Direct Phone: Not Available 









Type:

                    Public                
Employees: 
20 - 49

Revenue:  
5 - 10 Million

Industry:  
                        Biotech/Healthcare->BioTech/Drugs                    
SIC Code:  
                         2834  - Pharmaceutical Preparations








 BIOGRAPHY

 
                    Onconova Therapeutics's SVP Product Development is where Manoj Maniar is employed. On the other hand, the organization's CEO is Ramesh Kumar. They are based in Newtown, PA, and you can find their Lead411 profile filed under the Biotech/drugs industry. Manoj Maniar's profile contains twitter, phone numbers, linkedin, wiki, and contact information, and you can also find other Onconova Therapeutics email addresses on Lead411 with the @onconova.com domain.  Some possible email formats for Manoj Maniar are MManiar@onconova.com, Manoj.Maniar@onconova.com, Manoj@onconova.com, and Manoj_Maniar@onconova.com. If you sign up for our free trial you will see our email@onconova.com addresses.            


Similar People:
Manoj M - Technology
Paul Lombardo is Ness Technologies Inc's CEO. Their Senior Software Engineer is Manoj M. Their Lead411 profile is categorized under the Construction services industry. If you're checking for Ness Technologies Inc email addresses, these are also available on Lead411 with the @ness.com email format and possibly Manoj M's email. Ness Technologies Inc is based in Teaneck, NJ. You can also get Manoj M's linkedin info, twitter, phone numbers, wiki, and biography on their Lead411 profile. Their contact information is filed under the Construction services category.  Some possible email formats for Manoj M are MM@ness.com, Manoj.M@ness.com, Manoj@ness.com, and Manoj_M@ness.com. If you sign up for our free trial you will see our email@ness.com addresses.
Manoj M - Other
Trying to find Manoj M's email, wiki, phone numbers, twitter, biography, and linkedin data?  You can check out WEX Inc's profile on Lead411, where you can also get @wexinc.com contact information.  WEX Inc is an organization centered in South Portland, ME, which you can find on Lead411 under the Banks category.  Manoj M is their Front-End / JavaScript Developer.  Some possible email formats for Manoj M are MM@wexinc.com, Manoj.M@wexinc.com, Manoj@wexinc.com, and Manoj_M@wexinc.com. If you sign up for our free trial you will see our email@wexinc.com addresses.
Manoj M - Other
A Right Angle .Net Developer at ConocoPhillips based in Houston, TX, Manoj M has a comprehensive profile on Lead411. You can find the entry on Conocophillips in our Oil, gas, coal category. The company CEO is John Lowe. There are email addresses on their profile and may include Manoj M' email format too. You can also find other contact information like facebook, phone numbers, biography, wiki, and linkedin for Manoj M.  Some possible email formats for Manoj M are MM@conocophillips.com, Manoj.M@conocophillips.com, Manoj@conocophillips.com, and Manoj_M@conocophillips.com. If you sign up for our free trial you will see our email@conocophillips.com addresses.



Similar Employees:
Ramesh Kumar - Executive
Their President and CEO is Ramesh Kumar. Their Lead411 profile is categorized under the Biotech/drugs industry. If you're checking for Onconova Therapeutics email addresses, these are also available on Lead411 with the @onconova.com email addresses and possibly Ramesh Kumar's email. Onconova Therapeutics is based in Newtown, PA. You can also get Ramesh Kumar's linkedin info, twitter data, phone numbers, wiki and biography on their Lead411 profile. Their contact information is filed under the Biotech/drugs category.  Some possible email formats for Ramesh Kumar are RKumar@onconova.com, Ramesh.Kumar@onconova.com, Ramesh@onconova.com, and Ramesh_Kumar@onconova.com. If you sign up for our free trial you will see our email@onconova.com addresses.
Mark Guerin - Executive
Have you been looking for contact information, like phone numbers and emails, on Mark Guerin?  Lead411 provides data on him which include twitter, linkedin url, wiki, and biography.  There is also Onconova Therapeutics email addresses within the @onconova.com profile so Mark Guerin's email could be included.  Mark Guerin is part of the Onconova Therapeutics which has its main offices in Newtown, PA.  Currently holds the post of Chief Financial Officer.  You can find the company data on Lead411 under the Biotech/drugs industry.  Some possible email formats for Mark Guerin are MGuerin@onconova.com, Mark.Guerin@onconova.com, Mark@onconova.com, and Mark_Guerin@onconova.com. If you sign up for our free trial you will see our email@onconova.com addresses.

People Directory > Manoj Maniar




























































ONTX Manoj Maniar Insider Trades for Onconova Therapeutics Inc.


































X

Tweet
 

Share this bulletin

Get news bulletins by email

Bulletin

Dow and Nasdaq hit all-time highs at Wednesday opening bell »
        




Investor Alert







New York Markets Close in:



Market Snapshot
Winners and Losers







X

Tweet
 

Share this bulletin

Get news bulletins by email

Bulletin

Dow futures up 100 points »
        

















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































Onconova Therapeutics Inc.

                  NASDAQ: ONTX
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

Onconova Therapeutics Inc.



Market open
 --Real time quotes
Jul 26, 2017, 9:30 a.m.


ONTX

/quotes/zigman/72043667/composite


$
1.93




Change

-0.01
-0.52%

Volume
Volume 520
Real time quotes








/quotes/zigman/72043667/composite
Previous close

$
			1.99
		


$
				1.93
			
Change

-0.01
-0.52%





Day low
Day high
$1.91
$1.93










52 week low
52 week high

            $1.78
        

            $4.12
        


















Insider Activity


Individual




Manoj Maniar



Dr. Manoj Maniar is Senior Vice President-Product Development at Onconova Therapeutics, Inc.
Dr. Maniar was previously employed as Senior Director-Formulations & Drug Delivery by SRI International.
He received his undergraduate degree from the Bombay College of Pharmacy and a doctorate degree from the University of Connecticut.



Transactions


Date
Shares
Transaction
Value





06/30/2016
50


 
Derivative/Non-derivative trans. at $6.5 per share.


325





        Copyright 2017 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
    











            Officers and Executives
        





Dr. Ramesh  Kumar 
President, Chief Executive Officer & Director




Mr. Mark  Guerin 
CFO & Principal Accounting Officer




Dr. Steven M. Fruchtman 
Chief Medical Officer, SVP-Research & Development




Dr. Manoj  Maniar 
Senior Vice President-Product Development




Mr. David M. Stephon 
Senior Vice President-Quality Management




Dr. E.  Premkumar Reddy 
Director




Mr. Michael B. Hoffman 
Chairman




Mr. Jack E. Stover 
Independent Director




Dr. Viren  Mehta 
Independent Director




Mr. James J. Marino 
Independent Director




Dr. Jerome E. Groopman 
Independent Director




Dr. Henry S. Bienen 
Independent Director
















Log In




9:34 AM EDT
July 26, 2017


/marketstate/country/us
New York

	Open


/marketstate/country/uk
London

	Open


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
9:33aU.S. stocks open higher, hit records on round of strong corporate results
9:32aNasdaq Composite Index opens higher by 0.2%
9:32aDow Jones Industrial Average advances past intraday record high
9:31aS&P 500 opens higher by 0.1%
9:31aBoeing's stock soars 5.3% to record high in morning trade
9:30aStocks open higher; Boeing helps push Dow to record
9:28aMcDonald's stock price target raised to $176 from $172 at Instinet
9:28aCitigroup stock price target raised to $81 from $78 at Instinet
9:28aTexas Instruments stock price target raised to $80 from $75 at Instinet
9:27aA.O. Smith stock price target raised to $60 from $58 at Boenning & Scattergood
9:24aCORRECTEDState National to be acquired by Markel in deal valuing the insurer at nearly $890 million
9:23aFord shares are down 1.7% after Q2 earnings
9:22aDiana Containerships' stock plummets after plans for second reverse stock split in a month
9:21aShares of Verizon Communications are up more than 2%
9:19aShares of Dish Network are down 2.6% premarket
9:17aHealth-care fund managers say a spike in drugs and devices will produce big returns
9:15aDollar steadies as investors await Fed’s policy signals
9:13aA money manager fights the social pressure for ‘more house’
9:11aTreasury yields fall as investors await Fed policy statement
9:11aDiana Containerships' stock plummets 35% to 30 cents in premarket trade
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,702.08

+88.65
+0.41%





nasdaq

/quotes/zigman/12633936/realtime
6,426.48

+14.31
+0.22%





s&p 500

/quotes/zigman/3870025/realtime
2,479.58

+2.45
+0.10%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15






















































    Manoj Maniar | Onconova Therapeutics, Inc. | ZoomInfo.com








Manoj Maniar Ph.D. - Executive Bio, Compensation History, and Contacts - Equilar Atlas










 

















Log in | Sign up








x

 






As Featured In



















Manoj Maniar Ph.D.
Senior Vice President, Product Development at Onconova Therapeutics, Inc.


View Full Profile
Are you Manoj Maniar Ph.D.? Claim your profile


 


Sign up for Equilar Atlas and view Manoj Maniar Ph.D.'s full profile. 
With Equilar Atlas, you can:



IDENTIFY corporate executives in Manoj Maniar Ph.D.'s  network and community.
												FOLLOW changes in Manoj Maniar Ph.D.'s employment and money-in-motion.
												CONNECT with Manoj Maniar Ph.D. through your network of contacts.
												








Manoj Maniar Ph.D.'s Executive Work History


Current


Senior Vice President, Product Development, 
Onconova Therapeutics, Inc.


Past
To view Manoj Maniar Ph.D.'s complete executive work history, sign up now
Age
54

 
 


Manoj Maniar Ph.D.'s Biography




			Dr. Maniar has served as our Senior Vice President, Product Development since August 2005. Prior to joining us, Dr. Maniar was with SRI International, Inc., a nonprofit research institute, where he served as Senior Director, Formulations and Drug Delivery. Dr. Maniar received his B.S. in Pharmacy from Bombay College of Pharmacy and his Ph.D. in Pharmaceutics from the University of Connecticut.
		
Source: Onconova Therapeutics, Inc. on 04/12/2017
		
	

 






Sign up for Equilar Atlas and view Manoj Maniar Ph.D.'s full profile. 



												By accessing Equilar Atlas, you can view bios, network, salary and wealth events
												of industry-leading executives like Manoj Maniar Ph.D.. More specifically, you'll be able to:
												

IDENTIFY corporate executives in Manoj Maniar Ph.D.'s  network and community.
												FOLLOW changes in Manoj Maniar Ph.D.'s employment and money-in-motion.
												CONNECT with Manoj Maniar Ph.D. through your network of conections.
												




View Full Profile


 








Search for over 360,000 executive profiles.





/bio



													Example: Manoj Maniar Ph.D.


















Manoj Maniar Ph.D.'s Connections (29)





Sign up now to view Manoj Maniar Ph.D.'s 29 connections »









David R. Parkinson
Board Member, Dare Bioscience, Inc.









Jack E. Stover
Dir., President and Chief Executive Officer, Interpace Diagnostics Group, Inc.









Steven M. Fruchtman
Chief Medical Officer and Senior Vice President, Research and Development, Onconova Therapeutics, Inc.









Anne M. VanLent
Board Member, Ocera Therapeutics, Inc.









Viren Mehta
Former Board Member, Onconova Therapeutics, Inc.









Thomas J. McKearn
Board Member, Advaxis









Ajay Bansal
Chief Financial Officer, ViewRay, Inc.









Ramesh Kumar
Dir., President and Chief Executive Officer, Onconova Therapeutics, Inc.









Henry S. Bienen
Board Member, Onconova Therapeutics, Inc.









Michael B. Hoffman
Chairman of the Board, Onconova Therapeutics, Inc.








Popular Profiles






														Sign up now to view more executive profiles »
														









Thomas J. Lynch
Executive Chairman, TE Connectivity Ltd.









John J. Kita
EVP and CFO, A. O. Smith









Elon R. Musk
CEO and Chairman, Tesla









David J. O'Connor
President and CEO, The Madison Square Garden Company









Carl G. Annessa
EVP and COO, Hornbeck Offshore Services, Inc.












×

Claim Your Profile Coming Soon
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.

Done


Thank you for your interest.
Ok






			Browse executive profiles:
			
				 A
			
				 B
			
				 C
			
				 D
			
				 E
			
				 F
			
				 G
			
				 H
			
				 I
			
				 J
			
				 K
			
				 L
			
				 M
			
				 N
			
				 O
			
				 P
			
				 Q
			
				 R
			
				 S
			
				 T
			
				 U
			
				 V
			
				 W
			
				 X
			
				 Y
			
				 Z



Equilar Homepage
Equilar Atlas
Equilar Insight
Equilar BoardEdge
Equilar Engage
Research Services
Knowledge Network
About Us
Login

� 2017 Equilar All Rights Reserved. Privacy Policy
1100 Marshall Street, Redwood City, CA 94063 | Phone (650) 241-6600 | Fax (650) 701-0993


















Manoj Maniar - Senior Vice President, Product Development at Onconova Therapeutics, Inc.



























































                      NEWS HOME
                    

Advertising
Board and Executive Moves
Energy
Health Care
Hedge Funds
M & A
Private Equity
Technology








            You have  
            
9 free profiles

              left this month   
			      

                Start Your Free Trial ➤
              








            Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there?
            

                View on RelSci Pro ➤
              




























































































































Email







LinkedIn







Facebook







Google+







Tweet







Reddit





Permalink





Manoj Maniar
Senior Vice President, Product Development at Onconova Therapeutics, Inc.



Overview
In The News Relationships Paths
Education Career History Boards & Committees Public Holdings Transactions 


Manoj Maniar
Senior Vice President, Product Development at Onconova Therapeutics, Inc.



 Overview



Age



54
                                  (Born 1963)
                                              




Board Seats



1





Number of Relationships



                This person is connected to 397 people.
              






 In The News
          See more




GlobeNewswire
April 20, 2016





                        Onconova Announces Novel Dual Targeting of ARK5 and CDK4/6 by Pre-clinical Compound, ON 123300, in Presentation at 2016 American Association of Cancer Research (AACR) Annual Meeting                    







 Relationships
              See Details




Curtis R. Carlson

Founder at Practice of Innovation, LLC.




Randall E. McCoy

Chairman, President & Chief Executive Officer at Regenicin, Inc.





Craig A. Chambers

Managing Director, Security & Surveillance Group at SRI International




Stanley J. Rosenschein

Former Chief Scientist & General Manager at Autodesk, Inc.





John J. Young, Jr.

Director at SRI International




Krishna Kodukula

Executive-in-Residence at ShangPharma Innovation, Inc.





William Alan Jeffrey

Chief Executive Officer at SRI International




E. Premkumar Reddy

Professor & Director-Cancer Therapeutics Program at Icahn School of Medicine at Mount Sinai





Ramesh Kumar

Co-Founder at Onconova Therapeutics, Inc.




François E. Wilhelm

Former Chief Medical Officer & Senior Vice President at Onconova Therapeutics, Inc.







See 387 more listings with RelSci Professional.

Start My Free Trial ➤








See 387 More 


 


 Paths to Manoj Maniar



            Manoj Maniar          




 You



 Connections via Relationship Science



 Manoj Maniar






Sync your contacts to see how you can connect with Manoj Maniar.

Start My Free Trial ➤








See  More 


 


 Educational Background



Ph.D Pharmaceutics 


University of Connecticut

                  The University of Connecticut (UConn) is a public research university in Connecticut. Known as a Public Ivy,[3] UConn was founded in 1881 and is a Land Grant and Sea Grant college & member of the Space Grant Consortium. The institution serves more than 30,000 students on its six campuses, including more than 8,000 graduate students in multiple programs.[4]

UConn's main campus is in Storrs, Connecticut. The university's president is Susan Herbst.[5]

UConn is one of the founding institutions of the Hartford, Connecticut/Springfield, Massachusetts regional economic and cultural partnership alliance known as New England's Knowledge Corridor. UConn is a member of Universitas 21, a global network of 24 research-intensive universities, who work together to foster global citizenship and institutional innovation through research-inspired teaching and learning, student mobility, connecting students and staff, and promote advocacy for internationalisation.[6] UConn is accredited by the New England Association of Schools and Colleges.                




 


Bombay College of Pharmacy







 Career History



Senior Vice President, Product Development

                                    2005 - Current                


Onconova Therapeutics, Inc.


                  Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer. The company was founded by Ramesh Kumar and E. Premkumar Reddy on December 22, 1998 and is headquartered in Newtown, PA.                




Senior Director

                                    Prior                


SRI International


                  SRI International is an independent, 501(c)(3) nonprofit research institute conducting client-sponsored research and development for government, industry, foundations, and other organizations. SRI’s 2012 revenues were approximately $545 million.

Our work spans research, development, and deployment. We also bring our R&D innovations to the marketplace by licensing our intellectual property, creating new ventures, and providing products and services.

Since our founding in 1946 by Stanford University, SRI has been committed to discovery and to the application of science and technology for knowledge, commerce, prosperity, and peace. SRI became independent of the university in 1970, and we changed our name to SRI International in 1977.
Leadership

With representatives from the nonprofit and commercial sectors, a prestigious and active Board of Directors governs SRI. Our executive team creates and leads programs to solve clients' increasingly complex challenges. The team has a broad base of knowledge in science, engineering, and technology innovation, coupled with expertise in policy, growth, and business strategy.
SRI International Staff

SRI employs 2,500 people worldwide, including scientists, engineers, technologists, policy researchers, and corporate and support staff. More than 40 percent of our people have advanced educational degrees, and many are renowned leaders in their fields. Our seven R&D divisions and other groups are organized around broad disciplines and capabilities. Meet some of our staff members, and if you are interested in joining us visit Careers at SRI.

SRI has spun off more than 50 ventures such as Siri, Intuitive Surgical, Nuance Communications, and Tout.
mobile radar equipment                





 Boards & Committees



Non-Profit Boards ▾




Senior Director

                    Prior                  


SRI International

                    SRI International is an independent, 501(c)(3) nonprofit research institute conducting client-sponsored research and development for government, industry, foundations, and other organizations. SRI’s 2012 revenues were approximately $545 million.

Our work spans research, development, and deployment. We also bring our R&D innovations to the marketplace by licensing our intellectual property, creating new ventures, and providing products and services.

Since our founding in 1946 by Stanford University, SRI has been committed to discovery and to the application of science and technology for knowledge, commerce, prosperity, and peace. SRI became independent of the university in 1970, and we changed our name to SRI International in 1977.
Leadership

With representatives from the nonprofit and commercial sectors, a prestigious and active Board of Directors governs SRI. Our executive team creates and leads programs to solve clients' increasingly complex challenges. The team has a broad base of knowledge in science, engineering, and technology innovation, coupled with expertise in policy, growth, and business strategy.
SRI International Staff

SRI employs 2,500 people worldwide, including scientists, engineers, technologists, policy researchers, and corporate and support staff. More than 40 percent of our people have advanced educational degrees, and many are renowned leaders in their fields. Our seven R&D divisions and other groups are organized around broad disciplines and capabilities. Meet some of our staff members, and if you are interested in joining us visit Careers at SRI.

SRI has spun off more than 50 ventures such as Siri, Intuitive Surgical, Nuance Communications, and Tout.
mobile radar equipment                  





 Public Holdings






Restricted data only for RelSci Professional users.

Start My Free Trial ➤








See  More 


 


 Transactions



 Details Hidden



                  Onconova Therapeutics, Inc. raised money in a private placement transaction                                  





 Other Affiliations




              Manoj Maniar is affiliated with
                            Onconova Therapeutics, Inc., SRI International, SRI International.
            





You've reached your 10 free profiles limit this month.
Upgrade to RelSci Pro today to enjoy unlimited article views and much more!

Start My Free Trial  ➤

Still not convinced? Check out our full listing of features here.












Are you a RelSci Pro Subscriber?

Login to RelSci Pro 
                        ➤


Not a Pro Subscriber? Log in here to manage your alerts









 Keep me signed in.
        

Login  ➤



        Forgot your Password?
    

























 I have read the LexisNexis terms & conditions




Sign Me Up  ➤
















ONTXW Manoj Maniar Insider Trades for Onconova Therapeutics Inc. Wt


































X

Tweet
 

Share this bulletin

Get news bulletins by email

Bulletin

Dow and Nasdaq hit all-time highs at Wednesday opening bell »
        




Investor Alert







New York Markets Close in:



Market Snapshot
Winners and Losers







X

Tweet
 

Share this bulletin

Get news bulletins by email

Bulletin

Dow futures up 100 points »
        

















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































Onconova Therapeutics Inc. Wt

                  NASDAQ: ONTXW
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

Onconova Therapeutics Inc. Wt



Market open
 --Quotes are delayed by 20 min
Jul 25, 2017, 3:37 p.m.


ONTXW

/quotes/zigman/75394296/composite


$
0.45




Change

0.00
0.00%

Volume
Volume 300
Quotes are delayed by 20 min








/quotes/zigman/75394296/composite
Previous close

$
			0.45
		


$
				0.45
			
Change

0.00
0.00%





Day low
Day high
$0.45
$0.45










52 week low
52 week high

            $0.35
        

            $1.30
        


















Insider Activity


Individual




Manoj Maniar



Dr. Manoj Maniar is Senior Vice President-Product Development at Onconova Therapeutics, Inc.
Dr. Maniar was previously employed as Senior Director-Formulations & Drug Delivery by SRI International.
He received his undergraduate degree from the Bombay College of Pharmacy and a doctorate degree from the University of Connecticut.



Transactions


Date
Shares
Transaction
Value





06/30/2016
50


 
Derivative/Non-derivative trans. at $6.5 per share.


325





        Copyright 2017 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
    











            Officers and Executives
        





Dr. Ramesh  Kumar 
President, Chief Executive Officer & Director




Mr. Mark  Guerin 
CFO & Principal Accounting Officer




Dr. Steven M. Fruchtman 
Chief Medical Officer, SVP-Research & Development




Dr. Manoj  Maniar 
Senior Vice President-Product Development




Mr. David M. Stephon 
Senior Vice President-Quality Management




Dr. E.  Premkumar Reddy 
Director




Mr. Michael B. Hoffman 
Chairman




Mr. Jack E. Stover 
Independent Director




Dr. Viren  Mehta 
Independent Director




Mr. James J. Marino 
Independent Director




Dr. Jerome E. Groopman 
Independent Director




Dr. Henry S. Bienen 
Independent Director









Trending Tickers


/quotes/zigman/17636479/composite VUZI+15.60%


/quotes/zigman/237947/composite JCP-5.83%


/quotes/zigman/59392505/composite NUGT-2.93%


/quotes/zigman/59386294/composite JNUG-5.94%


/quotes/zigman/65801738/composite TLT+1.11%


X




Powered by














Log In




9:34 AM EDT
July 26, 2017


/marketstate/country/us
New York

	Open


/marketstate/country/uk
London

	Open


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
9:33aU.S. stocks open higher, hit records on round of strong corporate results
9:32aNasdaq Composite Index opens higher by 0.2%
9:32aDow Jones Industrial Average advances past intraday record high
9:31aS&P 500 opens higher by 0.1%
9:31aBoeing's stock soars 5.3% to record high in morning trade
9:30aStocks open higher; Boeing helps push Dow to record
9:28aMcDonald's stock price target raised to $176 from $172 at Instinet
9:28aCitigroup stock price target raised to $81 from $78 at Instinet
9:28aTexas Instruments stock price target raised to $80 from $75 at Instinet
9:27aA.O. Smith stock price target raised to $60 from $58 at Boenning & Scattergood
9:24aCORRECTEDState National to be acquired by Markel in deal valuing the insurer at nearly $890 million
9:23aFord shares are down 1.7% after Q2 earnings
9:22aDiana Containerships' stock plummets after plans for second reverse stock split in a month
9:21aShares of Verizon Communications are up more than 2%
9:19aShares of Dish Network are down 2.6% premarket
9:17aHealth-care fund managers say a spike in drugs and devices will produce big returns
9:15aDollar steadies as investors await Fed’s policy signals
9:13aA money manager fights the social pressure for ‘more house’
9:11aTreasury yields fall as investors await Fed policy statement
9:11aDiana Containerships' stock plummets 35% to 30 cents in premarket trade
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,700.67

+87.24
+0.40%





nasdaq

/quotes/zigman/12633936/realtime
6,426.42

+14.24
+0.22%





s&p 500

/quotes/zigman/3870025/realtime
2,479.36

+2.23
+0.09%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15


























































Manoj (Mark) Maniar specializes in San Diego CA Homes, Real Estate, and Property Listings












 












(858) 699-5899


Manoj (Mark) Maniar
Broker, MBA29+ Years Experienced in San Diegomanojjagu1@gmail.com
Property Gallery























Price
to
BedsNo min1234567
BathsNo min1+2+3+4+5+6+7+





"Where trust is a tradition"





BUYERS!
                  We have a common goal: Making you a homeowner. Let's make it happen!
                  Ensuring you exceptional service at every step of your home buying process.

Search listings from the convenience of your home.
Be the first to get new listings that match your criteria.
Get real estate market watch updates for listings in your area.
"For Buyers" - Your source for the latest tips, checklists and free reports.
Personal Consultation - Vast experience and knowledge you can rely on.
Financial advice - Loans, Mortgages, interest and tax benefits.
Community information and Utilities.

                  Find knowledgeable agents who know how to get the job done, get a good deal and are responsive to all your real estate needs. Providing you prompt service, personal guidance and professional competence from contract to settlement.

SELLERS!
                  Allow me to list your home for a quick sale. As a real estate specialist, I know what it takes to sell your home. I bring expert knowledge, valuable experience blended with the latest technology, a well-defined marketing plan, a cohesive network, energy, enthusiasm and the excitement of a job well done.


Detailed Home Evaluation Report and advice on the best price to list your home.
Vast exposure to your listing. 
Virtual tours to distinguish your listing.
"For Sellers" - Your source for the latest tips, checklists and free reports.
Personal Consultation - Vast experience and knowledge you can rely on.
Relocating - Everything you need to know about the neighborhood and transferring utilities.

                  If you are planning to place your home on the market, browse my website for valuable information on preparing your home for sale, pricing your home right, marketing it effectively and the home inspection processes.

                  I am passionate about my job, love my neighborhood and keep up with the latest trends and strategies so that I can pass them on to my clients.

Your satisfaction is my success!

Contact info



Manoj (Mark) ManiarBroker, MBAProperty Gallery

CalBRE License Number: 00850041

9396-b Mira Mesa Blvd, San Diego, CA 92126







Home PageContact MeSite MapAgent LoginClient Login

        ©1997-2017 Real Estate Websites by PropertyMinder. Privacy Policy, Terms of Use. All rights reserved.
      







Insider Trading - Maniar Manoj - Form 4 SEC Filings












Home |
Archives |
Products |
About |
Contact |
FAQ |



New User?
Sign Up | 
Sign In









Form 4 Filings


Insider Buys


Significant Buys


Penny StocksInsider Buying


Insider Sales




Insider Buy Sell Ratios


Stock Options


Insider TradingStock Screener


Insider TradingGraph View


Insider Watch





Sec Filings Insider Trading - Maniar Manoj





Select Time period: 
1 Month
2 Months
3 Months
6 Months
1 Year
2 Years
3 Years
4 Years
All Data
 

     



google

   



yahoo!



Send this page to:  

Blog
  



Digg

  



Reddit

  



Facebook

  



Stumble

  



del.icio.us








Enter Stock Ticker Symbol or Cik:




Cik Lookup...






Search By Company or Insider Name:







"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch ==>>

What is insider trading>>



Email a friend >>...







Historical filings delayed by 6 months. New user?
Sign Up for real time data.
Existing user?
Sign In

Stock options: Exercise, Award, Grant, Conversion



TransactionDate
ReportedDate
ExercisableExpiration
Company
Symnbol
InsiderRelationship
SharesTraded
ConversionPrice
SharesOwned
Filing




2016-12-15Option Award
2016-12-194:31 pm
N/A2026-12-15
Onconova Therapeutics Inc.
ONTX
Maniar ManojSVP - Product Development
5,587
$2.65
5,587(Direct)
View


2016-09-01Option Award
2016-09-013:28 pm
N/A2026-09-01
Onconova Therapeutics Inc.
ONTX
Maniar ManojSVP - Product Development
17,000
$3.24
17,000(Direct)
View


2016-06-30Exercise
2016-06-305:24 pm
N/AN/A
Onconova Therapeutics Inc.
ONTX
Maniar ManojSVP - Product Development
50
$6.5
10,342(Direct)
View


2016-06-30Exercise
2016-06-305:24 pm
2016-01-262026-01-26
Onconova Therapeutics Inc.
ONTX
Maniar ManojSVP - Product Development
50
$6.5
10,342(Direct)
View


2016-01-26Option Award
2016-01-285:42 pm
N/A2026-01-26
Onconova Therapeutics Inc.
ONTX
Maniar ManojSVP - Product Development
103,918
$0.65
103,918(Direct)
View


2015-09-25Option Award
2015-10-014:28 pm
N/A2025-09-25
Onconova Therapeutics Inc.
ONTX
Maniar ManojSVP - Product Development
40,000
$1.48
40,000(Direct)
View









    © 2005-2017 SecForm4.Com All rights reserved.
    Archives:
    2017 2016 2015 2014 2013 2012 ... 
    Wed, 26 Jul 2017 08:34:24 -0500
  

    SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
    SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC).
Terms of Use |
    Privacy Statement |
  








